Seoul, South Korea

Su-Sung Oh

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Kainos Medicine Inc.. Active years: 2018-2019.


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Su-Sung Oh in Cancer Treatment

Introduction

Su-Sung Oh is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel pharmaceutical compounds. With a total of 2 patents, his work focuses on creating effective therapeutic agents for combating cancer.

Latest Patents

Su-Sung Oh's latest patents include groundbreaking inventions aimed at improving cancer treatment. One of his patents is titled "Mutual prodrug comprising short chain fatty acids and zebularine or 1'-cyano-cytarabine for cancer treatment." This invention provides mutual prodrugs that combine anti-cancer nucleosides with short chain fatty acids. It outlines methods for producing these mutual prodrugs, as well as treatment methods that involve their administration. The mutual prodrugs can serve as therapeutic agents for various cancer diseases and conditions.

Another significant patent is "Bromodomain-inhibiting compounds and pharmaceutical composition comprising same for preventing or treating a cancer." This patent introduces a novel compound that exhibits bromodomain and extra terminal domain (BET) protein inhibiting activities. The pharmaceutical composition derived from this compound is useful for preventing or treating precancerous transformations or cancer.

Career Highlights

Su-Sung Oh is currently associated with Kainos Medicine Inc., where he continues to advance his research in cancer therapeutics. His work has garnered attention for its potential to improve treatment outcomes for cancer patients.

Collaborations

Su-Sung Oh collaborates with talented individuals in his field, including Sunmi Shin and Hyangmi Kim. Their combined expertise contributes to the innovative research being conducted at Kainos Medicine Inc.

Conclusion

Su-Sung Oh's contributions to cancer treatment through his innovative patents highlight the importance of research in developing effective therapies. His work continues to pave the way for advancements in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…